NatureCell Co

NatureCell Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NatureCell Co (007390.KQ) as of Oct 16, 2026 is -3.62 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 1.98 B KRW — a change of -283.09% (lower).

EBITDA

-3.62 BKRW

YoY

-283.09%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NatureCell Co is 2025 -3.62 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NatureCell Co was 2024 1.98 B KRW. It decreases by -283.09% lower compared to the previous year.

The NatureCell Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2016
-3.67 B KRW
Jan 1, 2017
-1.14 B KRW
Jan 1, 2018
2.43 B KRW
Jan 1, 2019
1.54 B KRW
Jan 1, 2022
-6.25 B KRW
Jan 1, 2023
-9.97 B KRW
Jan 1, 2024
1.98 B KRW
Jan 1, 2025
-3.62 B KRW
The NatureCell Co EBITDA history
YEAREBITDAYoY
-3.62 BKRW-283.09%
1.98 BKRW-119.84%
-9.97 BKRW+59.46%
-6.25 BKRW-505.04%
1.54 BKRW-36.38%
2.43 BKRW-313.65%
-1.14 BKRW-69.08%
-3.67 BKRW+203.46%
-1.21 BKRW-348.23%
487.47 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NatureCell Co Stock analysis

What does NatureCell Co do? NatureCell Co Ltd, listed on the Korean stock exchange with ticker 007390.KQ and ISIN KR7007390008, is a biotechnology company headquartered in Seoul, South Korea. Founded in 1992, the company operates in the Health Care sector with a focus on biotechnology. NatureCell employs 116 full-time staff and has been publicly traded since November 30, 1992. The company's business activities are structured into three primary segments. The Stem Cell Business segment involves the development of stem cell therapeutics, production of stem cell culture media, creation and sale of stem cell-based cosmetics, and provision of blood cell storage services. The Food Business segment encompasses manufacturing and selling fruit beverages like tomato juice and peach juice, canned drinks such as sikhye, fruit concentrates, and health-focused functional foods. The Hygiene Business segment focuses on producing and distributing health hygiene products including masks, disinfectants, and cleaning wipes. The company's official website is https://www.naturecell.co.kr/. NatureCell operates with a clear division of its operations across these segments, reflecting its diversified approach within the health care and biotechnology industries. NatureCell Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NatureCell Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NatureCell Co is -3.62 B KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NatureCell Co changed from 1.98 B KRW to -3.62 B KRW, representing a -283.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) NatureCell Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s NatureCell Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — NatureCell Co

All Key Metrics — NatureCell Co